I – Context Our concerns about what we call, figuratively, imprisonment and mastery of guilt in relation to the state’s civil liability goes back a […]
On February 5 of this year, Decree-Law No. 5/2017, of January 6, entered into force, which approved the general principles of advertising of medicines and […]
The new rules aimed at safeguarding transparency in the advertising of medicinal products and medical devices or in connection with their promotion are stimulating or […]
At the eHealth Summit, the topic on Public Procurement and Innovation was discussed by a panel composed of Sérgio Alves Ribeiro, BAS, João Oliveira, Chairman […]
Jane Kirkby, BAS’s attorney and partner, looks at the concept of Beneficiary Entities in the new rules for transparency in advertising of drugs and medical […]